Ann Morgan

854 total citations
22 papers, 482 citations indexed

About

Ann Morgan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ann Morgan has authored 22 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ann Morgan's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Asthma and respiratory diseases (5 papers). Ann Morgan is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Asthma and respiratory diseases (5 papers). Ann Morgan collaborates with scholars based in United Kingdom, United States and Switzerland. Ann Morgan's co-authors include Jennifer K Quint, Rosita Zakeri, Peter M. George, Liam Smeeth, Hannah Whittaker, Constantinos Kallis, Kieran Rothnie, Chloë I. Bloom, Steven J. Kiddle and James Potts and has published in prestigious journals such as CHEST Journal, BMJ and The Economic Journal.

In The Last Decade

Ann Morgan

20 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Morgan United Kingdom 10 346 103 86 67 37 22 482
Wakae Hasegawa Japan 11 229 0.7× 36 0.3× 120 1.4× 76 1.1× 16 0.4× 25 379
Hatice Canan Hasanoğlu Türkiye 12 254 0.7× 37 0.4× 91 1.1× 47 0.7× 11 0.3× 73 498
Emilia Sawicka Poland 10 169 0.5× 100 1.0× 43 0.5× 62 0.9× 7 0.2× 26 363
Oleh W. Hnatiuk United States 12 347 1.0× 45 0.4× 246 2.9× 75 1.1× 26 0.7× 22 549
Angela Kempel Germany 6 135 0.4× 71 0.7× 54 0.6× 50 0.7× 11 0.3× 8 613
İpek Kıvılcım Oğuzülgen Türkiye 12 213 0.6× 46 0.4× 166 1.9× 65 1.0× 10 0.3× 34 490
Frédéric Roca France 9 84 0.2× 118 1.1× 97 1.1× 63 0.9× 15 0.4× 37 365
Sunmi Ju South Korea 13 200 0.6× 30 0.3× 78 0.9× 81 1.2× 13 0.4× 35 419
Murat Yalçınsoy Türkiye 10 208 0.6× 43 0.4× 134 1.6× 62 0.9× 8 0.2× 47 360
Ayşegül Karalezli Türkiye 11 130 0.4× 25 0.2× 75 0.9× 32 0.5× 19 0.5× 60 354

Countries citing papers authored by Ann Morgan

Since Specialization
Citations

This map shows the geographic impact of Ann Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Morgan more than expected).

Fields of papers citing papers by Ann Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Morgan. The network helps show where Ann Morgan may publish in the future.

Co-authorship network of co-authors of Ann Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Morgan. A scholar is included among the top collaborators of Ann Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Morgan. Ann Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Ann, et al.. (2024). Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021. BMJ Open Respiratory Research. 11(1). e002273–e002273.
2.
Morgan, Ann, et al.. (2024). Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study. Thorax. 79(7). 624–631. 14 indexed citations
4.
Kallis, Constantinos, Ekaterina Maslova, Ann Morgan, et al.. (2023). Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study. Thorax. 78(12). 1175–1180. 8 indexed citations
5.
Morgan, Ann, et al.. (2023). Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review. BMJ Open Respiratory Research. 10(1). e001291–e001291. 53 indexed citations
6.
Morgan, Ann, et al.. (2023). Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England. BMC Pulmonary Medicine. 23(1). 256–256. 9 indexed citations
7.
Morgan, Ann, Ekaterina Maslova, Constantinos Kallis, et al.. (2023). Short-acting β2-agonists and exacerbations in children with asthma in England: SABINA Junior. ERJ Open Research. 9(2). 571–2022. 6 indexed citations
8.
Kallis, Constantinos, Ann Morgan, Louise Fleming, & Jennifer K Quint. (2023). Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population. Journal of Asthma and Allergy. Volume 16. 1065–1075. 2 indexed citations
9.
Leavy, Olivia C., Richard J. Allen, Luke M. Kraven, et al.. (2022). The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank. CHEST Journal. 163(2). 362–365. 4 indexed citations
10.
Morgan, Ann, Laura Portas, Hannah Whittaker, et al.. (2022). Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study. BMC Pulmonary Medicine. 22(1). 190–190. 6 indexed citations
12.
Zakeri, Rosita, Ann Morgan, Varun Sundaram, et al.. (2021). Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Medicine. 19(1). 179–179. 6 indexed citations
13.
Whittaker, Hannah, et al.. (2021). Post-Acute COVID-19 Sequelae in Cases Managed in the Community or Hospital in the UK: A Population Based Study. SSRN Electronic Journal. 1 indexed citations
14.
Morgan, Ann, Sarah‐Jo Sinnott, Liam Smeeth, Caroline Minassian, & Jennifer K Quint. (2020). Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study. BJGP Open. 5(2). BJGPO.2020.0117–BJGPO.2020.0117. 10 indexed citations
15.
Whittaker, Hannah, Chloë I. Bloom, Ann Morgan, et al.. (2020). Accelerated FEV1decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients. European Respiratory Journal. 57(3). 2000918–2000918. 31 indexed citations
16.
Morgan, Ann, Rosita Zakeri, & Jennifer K Quint. (2018). Defining the relationship between COPD and CVD: what are the implications for clinical practice?. Therapeutic Advances in Respiratory Disease. 12. 2469485564–2469485564. 228 indexed citations
17.
Morgan, Ann, et al.. (2017). Chronic Obstructive Pulmonary Disease and the Risk of Stroke. Annals of the American Thoracic Society. 14(5). 754–765. 27 indexed citations
18.
Morgan, Ann, Emily Herrett, Bianca De Stavola, Liam Smeeth, & Jennifer K Quint. (2016). COPD disease severity and the risk of venous thromboembolic events: a matched case–control study. International Journal of COPD. 11. 899–899. 18 indexed citations
19.
Morgan, Ann, et al.. (2016). Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol. BMJ Open. 6(11). e011898–e011898. 7 indexed citations
20.
MacNee, William, Ann Morgan, C G Wathen, Alexander Muir, & D. C. Flenley. (1985). Right Ventricular Performance during Exercise in Chronic Obstructive Pulmonary Disease. Respiration. 48(3). 206–215. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026